Navigation Links
DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial Results
Date:3/2/2011

tudy for ELADUR® by King
  • Initiation of Phase I in our ORADUR®-ADHD program  

  • In 2011, we look forward to:

  • Potential approval of REMOXY by the FDA and subsequent launch by Pfizer
  • Completion of the POSIDUR Phase III study
  • Reporting of Phase IIb results for ELADUR
  • Advancing our ORADUR-ADHD and other research and development programs
  • Potentially entering into additional collaborations

  • Highlights for DURECT in Fiscal Year 2010 and Major Potential Milestones over the Next 12-18 Months:

  • REMOXY.  We are looking forward to the anticipated June 23, 2011 PDUFA goal date.  In December 2010, King resubmitted the New Drug Application (NDA) for REMOXY to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008.  In July 2009, King met with the FDA to discuss the Complete Response Letter. Pfizer completed its acquisition of King in February 2011 and as a result has assumed the development and commercialization rights and obligations to REMOXY and to the three other licensed ORADUR-based opioid drug candidates (hydrocodone, hydromorphone and oxymorphone).  REMOXY, an investigational drug, is a unique long acting oral formulation of oxycodone intended to treat moderate to severe pain. Based on DURECT's ORADUR technology, which is covered by issued patents and pending patent applications owned by us, REMOXY is designed to resist common methods of prescription drug misuse and abuse.  


  • POSIDUR (SABER™-Bupivacaine) Post-Operative Pain Relief Depot.  In 2010 and early 2011, Nycomed completed two Phase II studies in Europe, one in hysterectomy and another in shoulder surgery.   In February 2011, we and Nycomed amended our agreement such that DURECT will have full control and financial resp
    '/>"/>


  • SOURCE DURECT Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
    2. DURECT Corporation Announces Third Quarter 2008 Financial Results
    3. DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call
    4. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
    5. Pharmos Corporation Reports 2008 Second Quarter Results
    6. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
    7. Genaera Corporation Announces Second Quarter Financial Results
    8. MannKind Corporation Reports Second Quarter Financial Results
    9. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
    10. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
    11. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/30/2015)... April 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... announced that it has commenced an underwritten public offering ... grant the underwriters a 30-day option to purchase up ... common stock offered in the public offering. The offering ... no assurance as to whether or when the offering ...
    (Date:4/30/2015)... , April 30, 2015 The following is ... of Directors of China Cord Blood Corp (NYSE: CO ... special committee of the independent directors of China Cord Blood ... privatization offer of $6.40 per share from Golden Meditech Holdings ... $6.40 per share would greatly benefit Golden Med and Mr. ...
    (Date:4/30/2015)... , April 30, 2015  Pfenex Inc. ... in the development of biosimilar therapeutics including high ... the closing of its previously announced underwritten public ... at a public offering price of $15.50 per ... the underwriters of their option to purchase up ...
    (Date:4/30/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: ... provider, today announced that its board of directors has ... 2015, from a consortium (the "Consortium") led by Dr. ... chief executive officer of the Company, and Ally Bridge ... "Transaction") involving the acquisition of all outstanding shares of ...
    Breaking Biology Technology:BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 4April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 5Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2WuXi PharmaTech Announces Receipt of Proposal 2WuXi PharmaTech Announces Receipt of Proposal 3WuXi PharmaTech Announces Receipt of Proposal 4WuXi PharmaTech Announces Receipt of Proposal 5WuXi PharmaTech Announces Receipt of Proposal 6
    (Date:4/2/2015)... 2, 2015 Fingerprint Cards (FPC) ... FPC1025 from the distributor World Peace Industrial Group (WPI), ... 2015 although the major part of the shipments will ... used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK ...
    (Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
    (Date:3/24/2015)... 24, 2015 Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) ... - Global Strategic Business Report" report to their offering. ... Biometrics in US$ Thousands by the following Segments: Face Biometrics, and ... Canada , Japan , ... Middle East & Africa , and ...
    Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
    ... The final agenda for the Conference on Cell Therapy ... is now available online at http://www.crf.org/celltherapy/the-conference/agenda . The ... the premier meeting dedicated to the evolving field of ... and vascular disease, as well as related diseases such ...
    ... Boulder, Colo., USA New Geology postings extend ... years; determine erosion rates for exposure of today,s ... pulses; call mudstones "so complicated as to almost ... the oldest rocks on Earth; postulate that biomarkers ...
    ... Philadelphia, PA, January 8, 2014 Food prepared away ... in nutrition than food prepared at home, but it ... purchased in the United States. Consumers tend to view ... fast-food restaurants, but some studies have found much higher ...
    Cached Biology News:Final agenda available for CRF Conference on Stem Cell Therapy for Heart Disease 2Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 2Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 3Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 4Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 5Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 6Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 7Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 8Geological Society of America's top journal, Geology, begins 2014 with 10 new articles 9Nutrition guidelines needed for full-service restaurant chains 2
    Polyclonal Antibody to PRG3...
    Goat polyclonal to MLH3 ( Abpromise for all tested applications). entrezGeneID: 27030 SwissProtID: Q9UHC1...
    Mouse monoclonal [2991] to C3a / C3a des Arg ( Abpromise for all tested applications). SwissProtID: P01024...
    Polyclonal Antibody to SHPRH...
    Biology Products: